Search Results - "Tianshu Liu"

Camrelizumab Plus Famitinib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Study.

Authors: Xu, Bei Zhu, Guopei Lu, Jin et al.

Source: Cancer Medicine. May2026, Vol. 15 Issue 5, p1-12. 12p.

Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring.

Authors: Jiao, Heng Lin, Siyun Gu, Jianmin et al.

Source: Molecular Cancer. 5/15/2025, Vol. 24 Issue 1, p1-16. 16p.

Deformation Driven Suction Cups: A Mechanics‐Based Approach to Wearable Electronics.

Authors: Lee, Seola Akerson, Andrew Pardakhtim, Roham et al.

Source: Advanced Science. 4/9/2026, Vol. 13 Issue 20, p1-14. 14p.

A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAF^V600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study.

Authors: Xicheng, Wang Yanhong, Deng Yanqiao, Zhang et al.

Source: Cancer Medicine. Mar2026, Vol. 15 Issue 3, p1-13. 13p.

Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R‐Loop Accumulation and DNA Repair Deficiencies.

Authors: Zhang, Chi Zhu, Yanjing Ai, Luoyan et al.

Source: Advanced Science. 2/13/2026, Vol. 13 Issue 9, p1-17. 17p.

Diagnostic characteristics of multimodality imaging for left ventricular lipoma: new insights on surgical intervention.

Authors: Liu, Tianshu Fang, Lingyun Shi, Jiawei et al.

Source: Cardiovascular Ultrasound. 3/28/2025, Vol. 23 Issue 1, p1-4. 4p.

This result is not displayed to guests.
Login for full access.

Anomalous pH‐Dependence of Ru for Hydrogen Electrochemistry.

Authors: Fang, Yanyan Wei, Cong Liu, Tianshu et al.

Source: Angewandte Chemie International Edition. 7/28/2025, Vol. 64 Issue 31, p1-8. 8p.

Bioinformatics and In-Silico Findings Reveal Candidate Genes for Tetralogy of Fallot via Integrative Multi-Omics Data.

Authors: Shi, Jiawei Wang, Zhen Bai, Ying et al.

Source: Congenital Heart Disease. 2025, Vol. 20 Issue 2, p213-229. 17p.

PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma.

Authors: Guo, Mengzhou Chen, Sinuo Sun, Jialei et al.

Source: Advanced Science. 8/14/2025, Vol. 12 Issue 30, p1-18. 18p.

Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer.

Authors: Qin, Shukui Xu, Rui-Hua Shen, Lin et al.

Source: OncoTargets & Therapy. Aug2021, Vol. 14, p4439-4450. 12p.

Impact of diabetes mellitus on myocardial function and clinical outcomes in patients with significant aortic regurgitation.

Authors: Tan, Yuting Zhang, Yujie Cai, Qiuyu et al.

Source: Cardiovascular Diabetology. 7/15/2025, Vol. 24 Issue 1, p1-12. 12p.

Recommendations for progression criteria during external randomised pilot trial design, conduct, analysis and reporting.

Authors: Mellor, Katie Albury, Charlotte Dutton, Susan J et al.

Source: Pilot & Feasibility Studies. 4/15/2023, Vol. 9 Issue 1, p1-10. 10p.

This result is not displayed to guests.
Login for full access.

Efficacy and safety of anti-HER2 therapy in solid tumors except breast cancer: a systematic-review and meta-analysis.

Authors: Xuan Chen Yuqing Li Yufu Lu et al.

Source: European Journal of Gynaecological Oncology. Jan2025, Vol. 46 Issue 1, p10-22. 13p.

Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers.

Authors: Zhihao Lu Mingfei Geng Yongtao Han et al.

Source: Cancer Biology & Medicine. Dec2024, Vol. 21 Issue 12, p1171-1184. 14p.

Left atrial strain brings new insights for evaluating early diastolic dysfunction in patients with well‐functioning bicuspid aortic valve.

Authors: Tan, Yuting Deng, Wenhui Liu, Tianshu et al.

Source: Echocardiography. Nov2023, Vol. 40 Issue 11, p1243-1250. 8p.

Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial.

Authors: Liu, Dan Zhou, Jun Wang, Yongsheng et al.

Source: BMC Medicine. 10/24/2022, Vol. 20 Issue 1, p1-11. 11p.

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.

Authors: Jifang Gong Tianshu Liu Qingxia Fan et al.

Source: BMC Cancer. 2/8/2016, Vol. 16, p1-9. 9p. 1 Diagram, 2 Charts, 2 Graphs.

Benefits of multi‐disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis.

Authors: Lv, Yang Feng, Qing‐Yang Wei, Ye et al.

Source: Clinical & Translational Medicine. Jul2020, Vol. 10 Issue 3, p1-4. 4p.